Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PGNY

Progyny Inc

Feb 13 • 04:00PM ET

20.69

-0.29 -1.38 %

Healthcare • Healthcare Plans • USA • NASD

Peers: OSCR CNC MOH HUM UNH CVS CI CLOV GDRX AMWL

| Held by: IJR VTI VB IWM VBK VXF SPSM IJT IWO VTWO

Index	RUT	P/E	32.76	EPS (ttm)	0.63	Insider Own	16.13%	Shs Outstand	86.15M	Perf Week	-5.74%
Market Cap	1.78B	Forward P/E	22.06	EPS next Y	0.94	Insider Trans	0.37%	Shs Float	72.31M	Perf Month	-20.79%
Enterprise Value	1.47B	PEG	0.85	EPS next Q	0.15	Inst Own	94.41%	Short Float	3.94%	Perf Quarter	-14.04%
Income	56.57M	P/S	1.41	EPS this Y	15.61%	Inst Trans	0.91%	Short Ratio	1.96	Perf Half Y	-8.25%
Sales	1.27B	P/B	3.18	EPS next Y	42.34%	ROA	7.77%	Short Interest	2.85M	Perf YTD	-19.43%
Book/sh	6.50	P/C	5.17	EPS next 5Y	25.91%	ROE	11.37%	52W High	28.75 -28.03%	Perf Year	-5.74%
Cash/sh	4.00	P/FCF	9.22	EPS past 3/5Y	-4.58% -	ROIC	9.67%	52W Low	17.98 15.09%	Perf 3Y	-35.90%
Dividend Est.	-	EV/EBITDA	16.24	Sales past 3/5Y	32.60% 38.42%	Gross Margin	22.94%	Volatility	3.54% 3.97%	Perf 5Y	-58.95%
Dividend TTM	-	EV/Sales	1.16	EPS Y/Y TTM	8.70%	Oper. Margin	6.77%	ATR (14)	0.96	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.96	Sales Y/Y TTM	11.41%	Profit Margin	4.46%	RSI (14)	26.89	Recom	1.45
Dividend Gr. 3/5Y	- -	Current Ratio	2.96	EPS Q/Q	38.34%	SMA20	-11.52%	Beta	1.00	Target Price	30.91
Payout	0.00%	Debt/Eq	0.05	Sales Q/Q	9.32%	SMA50	-16.85%	Rel Volume	1.44	Prev Close	20.98
Employees	680	LT Debt/Eq	0.04	Earnings	Feb 26 AMC	SMA200	-9.51%	Avg Volume	1.45M	Price	20.69
IPO	Oct 25, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.92% 4.71%	Trades		Volume	2,087,652	Change	-1.38%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-20-26	Upgrade	Citizens JMP	Mkt Perform → Mkt Outperform	$30
Jan-08-26	Upgrade	Truist	Hold → Buy	$34
Dec-09-25	Initiated	Barclays	Overweight	$29
Nov-12-25	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$30
Jul-08-25	Upgrade	Leerink Partners	Market Perform → Outperform	$28
Dec-02-24	Downgrade	JP Morgan	Overweight → Neutral	$17
Nov-13-24	Downgrade	Truist	Buy → Hold	$26 → $19
Sep-19-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Aug-07-24	Downgrade	Leerink Partners	Outperform → Market Perform	$31 → $25
Aug-07-24	Downgrade	Canaccord Genuity	Buy → Hold	$37 → $24
Aug-07-24	Downgrade	BTIG Research	Buy → Neutral
Jul-16-24	Initiated	JMP Securities	Mkt Outperform	$36
May-10-24	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-26-24	Initiated	Leerink Partners	Outperform	$49
Jan-03-24	Initiated	Barclays	Overweight	$48
Sep-27-23	Initiated	Canaccord Genuity	Buy	$46
May-22-23	Initiated	BTIG Research	Buy	$50
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight	$44
Jan-05-23	Downgrade	SVB Leerink	Outperform → Mkt Perform	$34
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight	$55

Show Previous Ratings

Feb-12-26 02:46PM	Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report (GlobeNewswire)
Jan-22-26 07:20AM	Progyny price target raised to $35 from $30 at BTIG (TipRanks)
03:23AM	Progyny, Inc. (PGNY) Supported by Analysts as Earnings Visibility Improves (Insider Monkey)
Jan-20-26 03:10PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Jan-14-26 11:35PM	3 Hyped Up Stocks That Concern Us (StockStory) -6.93%
10:07AM	Loading…
Jan-12-26 10:07AM	Zacks Industry Outlook Highlights Medpace, Enhabit and Progyny (Zacks) +5.30%
08:00AM	Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:15AM	Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out? (Zacks)
09:04AM	3 Medical Service Industry Stocks Set to Tackle Workforce Challenges (Zacks)
Jan-08-26 11:36AM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Dec-31-25 11:04PM	2 Reasons PGNY is Risky and 1 Stock to Buy Instead (StockStory)
Dec-23-25 09:15AM	Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run? (Zacks) -5.16%
Dec-22-25 09:15AM	BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run? (Zacks)
Dec-16-25 11:32PM	3 Healthcare Stocks We're Skeptical Of (StockStory)
Dec-15-25 12:00PM	Progyny (PGNY) Upgraded to Buy: Here's What You Should Know (Zacks)
11:31PM	Loading…
Dec-08-25 11:31PM	1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds (StockStory)
Dec-07-25 11:39PM	2 Stocks Under $50 on Our Watchlist and 1 We Find Risky (StockStory)
Nov-25-25 09:15AM	Pediatrix Medical Group, Inc. (MD) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-24-25 12:45PM	Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Nov-20-25 09:23AM	New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action (GlobeNewswire)
Nov-18-25 09:15AM	Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-17-25 10:37PM	A Look Back at Health Insurance Providers Stocks' Q3 Earnings: Progyny (NASDAQ:PGNY) Vs The Rest Of The Pack (StockStory) +9.25%
Nov-14-25 11:40AM	PGNY vs. HQY: Which Stock Is the Better Value Option? (Zacks)
Nov-13-25 12:33PM	Progyny, Inc. to Present at Jefferies Global Healthcare Conference (GlobeNewswire)
12:37AM	5 Must-Read Analyst Questions From Progyny's Q3 Earnings Call (StockStory)
Nov-12-25 11:35PM	3 Inflated Stocks with Warning Signs (StockStory)
09:45AM	Carvana initiated, AT upgraded: Wall Street's top analyst calls (The Fly)
Nov-07-25 01:02PM	Why Progyny Stock Is Soaring Today (Motley Fool) +24.21%
09:21AM	PGNY Q3 Deep Dive: Product Expansion and Client Diversification Drive Momentum (StockStory)
12:08AM	Progyny Inc (PGNY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions (GuruFocus.com)
05:20PM	Loading…
Nov-06-25 05:20PM	Progyny (PGNY) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:13PM	Progyny: Q3 Earnings Snapshot (Associated Press Finance)
04:08PM	Progyny (NASDAQ:PGNY) Reports Upbeat Q3, Stock Soars (StockStory)
04:01PM	Progyny, Inc. Announces Third Quarter 2025 Results (GlobeNewswire)
Nov-05-25 07:36AM	Earnings To Watch: Progyny Inc (PGNY) Reports Q3 2025 Result (GuruFocus.com)
Nov-04-25 10:09PM	Progyny (PGNY) Q3 Earnings: What To Expect (StockStory)
Oct-27-25 03:13AM	3 Small-Cap Stocks with Warning Signs (StockStory)
Oct-23-25 01:08PM	Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report (GlobeNewswire)
09:40AM	Are Investors Undervaluing Progyny (PGNY) Right Now? (Zacks)
Oct-22-25 04:55PM	Checking In on The Trade Desk, Bristol Myers Squibb, and Other Stocks (Motley Fool)
09:28AM	Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause (GlobeNewswire)
Oct-07-25 09:40AM	Is Progyny (PGNY) Stock Undervalued Right Now? (Zacks)
09:30AM	Progyny CEO Named World Economic Forum Champion for Women's Health (GlobeNewswire)
Oct-02-25 12:04AM	3 Reasons to Avoid PGNY and 1 Stock to Buy Instead (StockStory)
Sep-26-25 08:05AM	A Healthcare Debate: Progyny vs. Hims & Hers (Motley Fool)
Sep-15-25 11:32PM	Health Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY) (StockStory)
Sep-05-25 02:36PM	Why Progyny (PGNY) Stock Is Trading Lower Today (StockStory)
Sep-01-25 12:20PM	Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock (Zacks)
09:15AM	CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-27-25 12:32PM	Progyny (PGNY) Stock Trades Up, Here Is Why (StockStory)
Aug-21-25 12:33AM	1 Russell 2000 Stock with Impressive Fundamentals and 2 We Ignore (StockStory)
Aug-18-25 02:40PM	Progyny (PGNY) Stock Is Up, What You Need To Know (StockStory)
Aug-14-25 01:35AM	5 Must-Read Analyst Questions From Progyny's Q2 Earnings Call (StockStory)
Aug-12-25 09:00AM	URA Advances Womens Health with First-of-its-Kind Support for Pregnancy and Menopause, Bridging Gaps in Care with Personalized Biometrics and Clinical Integrations (Business Wire)
03:07AM	PGNY Q2 Deep Dive: Product Expansion and Client Diversification Drive Upbeat Guidance (StockStory)
Aug-08-25 03:38AM	Progyny Inc (PGNY) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Partnerships ... (GuruFocus.com)
Aug-07-25 06:20PM	Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates (Zacks)
05:30PM	Progyny: Q2 Earnings Snapshot (Associated Press Finance)
04:48PM	Progyny (NASDAQ:PGNY) Beats Expectations in Strong Q2, Full-Year Sales Guidance is Optimistic (StockStory)
04:02PM	Progyny, Inc. Announces Second Quarter 2025 Results (GlobeNewswire)
Aug-05-25 11:16PM	Progyny Earnings: What To Look For From PGNY (StockStory)
Aug-04-25 06:15PM	Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-01-25 07:15AM	BrightSpring Health Services, Inc. (BTSG) Q2 Earnings and Revenues Beat Estimates (Zacks)
Jul-31-25 10:00AM	Progyny (PGNY) Earnings Expected to Grow: Should You Buy? (Zacks)
Jul-30-25 09:19AM	New Progyny Study Reveals Gap Between Perceptions and Realities in Women's Health Benefits Coverage (GlobeNewswire)
Jul-24-25 12:10PM	Will Progyny (PGNY) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-21-25 01:15PM	Why Progyny (PGNY) Stock Is Up Today (StockStory)
Jul-18-25 12:25PM	Why Progyny (PGNY) Stock Is Falling Today (StockStory)
Jul-10-25 09:06AM	Progyny Partners with URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause (GlobeNewswire)
09:06AM	Progyny Partners with OURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause (GlobeNewswire)
Jul-09-25 07:35AM	Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? (Zacks)
Jul-08-25 08:09AM	Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report (GlobeNewswire) +13.15%
Jun-30-25 08:55AM	Progyny's Q1 Earnings Call: Our Top 5 Analyst Questions (StockStory)
Jun-26-25 12:33AM	1 Stock Under $50 with Exciting Potential and 2 to Question (StockStory)
Jun-24-25 02:07PM	Teladoc (TDOC) Moves 14.4% Higher: Will This Strength Last? (Zacks)
10:42AM	Exelixis (EXEL) Surges 7.4%: Is This an Indication of Further Gains? (Zacks)
10:40AM	Strength Seen in Nektar (NKTR): Can Its 12.1% Jump Turn into More Strength? (Zacks)
09:10AM	Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women's Health (GlobeNewswire)
08:54AM	Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength? (Zacks)
07:56AM	RGC Resources (RGCO) Surges 9.1%: Is This an Indication of Further Gains? (Zacks)
07:31AM	GeneDx Holdings (WGS) Moves 19.0% Higher: Will This Strength Last? (Zacks)
04:41AM	Strength Seen in Mobileye (MBLY): Can Its 11.6% Jump Turn into More Strength? (Zacks)
Jun-10-25 09:02AM	Progyny Joins Amazon's Health Benefits Connector Program as First Women's Health and Family Building Solution (GlobeNewswire)
May-29-25 09:03AM	Progyny Adds Distinguished Healthcare Executive Elizabeth Bierbower to Board of Directors (GlobeNewswire)
May-20-25 12:01AM	3 Reasons PGNY is Risky and 1 Stock to Buy Instead (StockStory)
May-18-25 11:35PM	Q1 Earnings Outperformers: Progyny (NASDAQ:PGNY) And The Rest Of The Health Insurance Providers Stocks (StockStory)
May-14-25 09:05AM	Progyny Appoints Two Renowned Women's Health Experts to Medical Advisory Board (GlobeNewswire)
May-12-25 03:58PM	Progyny, Inc. to Present at BofA Securities 2025 Health Care Conference (GlobeNewswire)
May-09-25 11:46AM	Q1 2025 Progyny Inc Earnings Call (Thomson Reuters StreetEvents) -9.33%
03:44AM	Progyny Inc (PGNY) Q1 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Expansions (GuruFocus.com)
May-08-25 06:55PM	Progyny (PGNY) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:55PM	Progyny: Q1 Earnings Snapshot (Associated Press Finance)
04:14PM	Progyny, Inc. Announces First Quarter 2025 Results (GlobeNewswire)
11:40AM	GDRX vs. PGNY: Which Stock Should Value Investors Buy Now? (Zacks)
09:25AM	Progyny Inc (PGNY) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
May-07-25 05:35PM	Progyny Q1 2025 Earnings Preview (Seeking Alpha)
01:10PM	Solventum Q1 Earnings Likely to Reflect Higher Costs & Expenses (Zacks)
May-06-25 01:09PM	Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates? (Zacks)
07:11AM	MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings? (Zacks)
May-05-25 02:48PM	Progyny Stock Sees RS Rating Improve To 73 (Investor's Business Daily)

Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 11 '25	Sale	25.50	459	11,704	46,983	Dec 15 04:12 PM
Livingston Mark S.	Officer	Dec 11 '25	Proposed Sale	25.50	459	11,704		Dec 11 02:55 PM
Swartz Allison	EVP, GC	Dec 04 '25	Sale	24.59	530	13,033	72,719	Dec 08 04:23 PM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Dec 02 '25	Sale	25.50	213	5,432	47,921	Dec 04 04:17 PM
Swartz Allison	Officer	Dec 04 '25	Proposed Sale	24.59	530	13,033		Dec 04 09:41 AM
Swartz Allison	EVP, GC	Nov 28 '25	Sale	26.87	2,398	64,434	73,657	Dec 02 04:15 PM
Livingston Mark S.	Officer	Dec 02 '25	Proposed Sale	25.50	213	5,432		Dec 02 10:24 AM
Swartz Allison	Officer	Nov 28 '25	Proposed Sale	26.87	2,398	64,434		Nov 28 09:39 AM
Livingston Mark S.	CHIEF FINANCIAL OFFICER	Nov 17 '25	Sale	25.50	21,303	543,226	48,358	Nov 19 05:03 PM
Payson Norman	Director	Nov 14 '25	Option Exercise	1.45	36,224	52,525	56,954	Nov 18 04:48 PM
Livingston Mark S.	Officer	Nov 17 '25	Proposed Sale	25.50	21,303	543,226		Nov 17 12:31 PM
Anevski Peter	CHIEF EXECUTIVE OFFICER	Nov 13 '25	Buy	24.29	79,500	1,930,896	680,251	Nov 17 08:22 AM
Swartz Allison	EVP, GC	Sep 04 '25	Sale	23.53	599	14,094	77,407	Sep 05 04:39 PM
Swartz Allison	Officer	Sep 04 '25	Proposed Sale	23.53	599	14,094		Sep 04 09:35 AM
Swartz Allison	EVP, GC	Aug 28 '25	Sale	22.96	2,398	55,058	79,697	Sep 02 05:04 PM
Swartz Allison	Officer	Aug 28 '25	Proposed Sale	22.96	2,398	55,058		Aug 28 11:28 AM
GORDON KEVIN K	Director	Aug 11 '25	Sale	22.04	2,500	55,088	12,501	Aug 13 06:12 PM
GORDON KEVIN K	Director	Aug 11 '25	Proposed Sale	22.04	2,500	55,088		Aug 11 01:58 PM
Scott Cheryl	Director	Jun 11 '25	Sale	22.07	2,675	59,037	14,112	Jun 12 05:07 PM
Scott Cheryl	Director	Jun 11 '25	Proposed Sale	22.07	2,675	59,039		Jun 11 12:44 PM
Cohen Fred E	Former Director	Jun 03 '25	Proposed Sale	21.68	62,244	1,349,450		Jun 03 12:05 PM

Open in Screener

VCYT

Veracyte Inc

Feb 13 • 04:00PM ET

35.77

+0.62 1.76 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: EXAS ILMN GH BIO NTRA MYGN CDNA QGEN FLGT CRL

| Held by: IJR VTI VB ARKK FBT IWM XBI VBK ARKG VXF

Index	RUT	P/E	94.21	EPS (ttm)	0.38	Insider Own	2.16%	Shs Outstand	79.03M	Perf Week	-1.16%
Market Cap	2.83B	Forward P/E	22.86	EPS next Y	1.56	Insider Trans	-10.01%	Shs Float	77.34M	Perf Month	-15.74%
Enterprise Value	2.50B	PEG	0.30	EPS next Q	0.41	Inst Own	110.93%	Short Float	7.28%	Perf Quarter	-15.44%
Income	30.32M	P/S	5.71	EPS this Y	436.38%	Inst Trans	0.43%	Short Ratio	6.58	Perf Half Y	19.07%
Sales	495.14M	P/B	2.25	EPS next Y	-5.90%	ROA	2.29%	Short Interest	5.63M	Perf YTD	-15.04%
Book/sh	15.91	P/C	7.72	EPS next 5Y	76.17%	ROE	2.49%	52W High	50.71 -29.46%	Perf Year	-9.65%
Cash/sh	4.64	P/FCF	28.79	EPS past 3/5Y	- -	ROIC	2.34%	52W Low	22.61 58.20%	Perf 3Y	42.34%
Dividend Est.	-	EV/EBITDA	34.84	Sales past 3/5Y	26.63% 29.93%	Gross Margin	66.85%	Volatility	4.65% 4.75%	Perf 5Y	-52.77%
Dividend TTM	-	EV/Sales	5.05	EPS Y/Y TTM	375.89%	Oper. Margin	9.98%	ATR (14)	1.77	Perf 10Y	538.75%
Dividend Ex-Date	-	Quick Ratio	5.94	Sales Y/Y TTM	16.41%	Profit Margin	6.12%	RSI (14)	36.20	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	6.23	EPS Q/Q	24.34%	SMA20	-7.33%	Beta	1.92	Target Price	49.18
Payout	0.00%	Debt/Eq	0.03	Sales Q/Q	13.82%	SMA50	-13.73%	Rel Volume	0.76	Prev Close	35.15
Employees	824	LT Debt/Eq	0.03	Earnings	Feb 25 AMC	SMA200	5.23%	Avg Volume	856.06K	Price	35.77
IPO	Oct 30, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	59.13% 5.52%	Trades		Volume	654,135	Change	1.76%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-02-25	Resumed	Morgan Stanley	Underweight	$48
Oct-20-25	Initiated	Canaccord Genuity	Hold	$40
Mar-20-25	Initiated	Craig Hallum	Buy	$45
Dec-05-24	Downgrade	Goldman	Buy → Neutral	$38 → $37
Nov-15-24	Initiated	Wolfe Research	Outperform	$50
Oct-16-24	Initiated	UBS	Buy	$43
Oct-10-24	Initiated	Guggenheim	Buy	$40
Feb-23-24	Reiterated	Needham	Buy	$30 → $33
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$33
Jan-07-22	Initiated	Stephens	Overweight	$52
Nov-18-21	Resumed	Goldman	Buy	$60
Jun-15-21	Initiated	Raymond James	Outperform	$45
Feb-18-21	Resumed	Needham	Buy	$88
Jan-28-21	Initiated	Truist	Buy	$61
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$48
Sep-09-20	Initiated	Morgan Stanley	Underweight	$35
Jul-31-19	Initiated	Lake Street	Buy	$35
Jul-02-19	Initiated	Needham	Buy	$33
Nov-29-18	Downgrade	Janney	Buy → Neutral

Show Previous Ratings

Feb-13-26 09:39AM	Here's How Charles River Stock Is Placed Ahead of Q4 Earnings (Zacks)
08:55AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Feb-11-26 01:34PM	BD Merges Biosciences & Diagnostics Business With Waters (Zacks)
Feb-10-26 12:20PM	GEHC Launches ReadyFix Fleet Management to Boost ECG Efficiency (Zacks)
11:22AM	Will DXCM Deliver Q4 Earnings Beat on G7 Stabilization, Volume Growth? (Zacks)
08:57AM	Loading…
08:57AM	Labcorp's Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
Feb-09-26 12:58PM	PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data (Zacks)
10:40AM	GEHC Strengthens AI Fetal Ultrasound via Diagnoly Collaboration (Zacks)
08:02AM	Strength in Cardiovascular Unit Likely to Lift MDT's Q3 Performance (Zacks)
Feb-06-26 09:45AM	Here's How Quest Diagnostics Is Placed Ahead of Q4 Earnings (Zacks)
Feb-05-26 05:40PM	Mettler-Toledo (MTD) Q4 Earnings and Revenues Beat Estimates (Zacks)
12:56PM	Cigna Q4 Earnings Beat Estimates on Higher Specialty Volumes (Zacks)
12:33PM	DXCM Upgrades Stelo With AI-Powered Smart Meal Logging Features (Zacks)
09:35AM	Veracyte (VCYT) Loses 20.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Feb-04-26 05:15PM	Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 (Business Wire)
12:57PM	Loading…
12:57PM	Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test (Zacks)
12:51PM	Here's Why You Should Add Masimo Stock to Your Portfolio Now (Zacks)
10:23AM	Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect (Zacks)
09:45AM	Here's Why Veracyte (VCYT) is a Strong Growth Stock (Zacks)
08:47AM	Will Pharmacy and Consumer Wellness Segment Lead CVS' Q4 Earnings? (Zacks)
Feb-03-26 01:13PM	GEHC Wins FDA Clearance & CE Mark for Allia Moveo, Marks Global Debut (Zacks)
11:38AM	Zimmer Biomet to Report Q4 Earnings: Here's What to Expect (Zacks)
Feb-02-26 11:57AM	BD & Envetec Showcase Closed-Loop Recycling Solution for Lab Plastics (Zacks)
09:37AM	ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance (Zacks)
09:13AM	Can Cannabis Strength in Canada Drive Canopy's Q3 Earnings? (Zacks)
Jan-30-26 01:34PM	GRAIL Submits FDA PMA for Galleri Multi-Cancer Early Detection Test (Zacks)
09:55AM	Here's Why Veracyte (VCYT) Is a Great 'Buy the Bottom' Stock Now (Zacks)
08:28AM	HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash (Zacks)
Jan-29-26 01:32PM	Reasons to Retain Avanos Medical Stock in Your Portfolio Now (Zacks)
01:28PM	Organon Completes Divesture of JADA System to Laborie Medical (Zacks)
08:02AM	Loading…
08:02AM	Here's How Align Technology Is Placed Ahead of Q4 Earnings (Zacks)
Jan-28-26 12:21PM	Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums (Zacks)
11:26AM	QT Imaging & Olea Medical Partner to Enhance Cloud Imaging Platform (Zacks)
09:11AM	Will Higher Dupixent Profits, Eylea HD Sales Drive REGN's Q4 Earnings? (Zacks)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
07:46AM	PAHC Q2 Earnings Preview: Animal Health Momentum Likely to Aid Results (Zacks)
07:43AM	Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings (Zacks)
07:27AM	Will Robust MedSurg Performance Fuel Boston Scientific's Q4 Earnings? (Zacks)
07:26AM	STERIS' Q3 Earnings on Deck: What's in Store for the Stock? (Zacks)
Jan-27-26 12:19PM	Here's Why You Should Add Merit Medical Stock to Your Portfolio Now (Zacks)
12:07PM	ISRG's da Vinci Gets FDA Nod for Advanced Cardiac Procedures (Zacks)
07:54AM	Resmed's Q2 Earnings on Deck: What's in Store for the Stock? (Zacks)
07:53AM	CLPT Gets EU MDR Certification for ClearPoint Navigation Software (Zacks)
Jan-26-26 12:10PM	Why Veracyte (VCYT) is Poised to Beat Earnings Estimates Again (Zacks)
Jan-23-26 01:50PM	WST Launches Synchrony S1 Prefillable Syringe at Pharmapack (Zacks)
07:17AM	Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings? (Zacks)
Jan-22-26 11:08AM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
09:50AM	Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term (Zacks)
03:25AM	Veracyte, Inc. (VCYT) Sees Analyst Support as Guggenheim Reaffirms Buy Rating (Insider Monkey)
Jan-21-26 01:29PM	Centene Expands Palliative Care Access in Ohio Through Tuesday Health (Zacks)
11:43AM	BD Gets FDA 510(k) Approval for EnCor EnCompass Breast Biopsy System (Zacks)
Jan-19-26 12:40PM	Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology (Zacks)
07:37AM	Will Robust Adult Nutrition Business Performance Fuel ABT's Q4 Earnings? (Zacks)
Jan-14-26 01:11PM	Option Care Health Stock Earns Healthy RS Rating Upgrade (Investor's Business Daily)
Jan-13-26 10:45AM	NTRA & NVDA Partner to Improve AI Models for Precision Medicine (Zacks)
Jan-12-26 08:57AM	RVTY & Eli Lilly Partner to Expand Access to AI Drug Discovery Models (Zacks)
Jan-11-26 04:30PM	Veracyte Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Business Wire)
Jan-08-26 09:00AM	The Zacks Rank Explained: How to Find Strong Buy Medical Stocks (Zacks)
Jan-07-26 12:24PM	BFLY to Extend 3D Imaging Capabilities to Butterfly Garden Developers (Zacks)
Jan-05-26 12:51PM	Here's Why You Should Retain Masimo Stock in Your Portfolio Now (Zacks)
Dec-31-25 07:25AM	Smart Oncology: 5 Stocks Chasing the $317B Prize (PR Newswire)
Dec-30-25 11:48PM	Morgan Stanley Initiates Coverage Of Veracyte, Inc. (VCYT) (Insider Monkey)
10:42AM	RBOT Enters Strategic Software Partnership to Streamline Development (Zacks)
05:48AM	Zacks Industry Outlook Highlights Veracyte, IDEXX Laboratories and Intuitive Surgical (Zacks)
Dec-29-25 04:30PM	Veracyte to Participate in the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
07:23AM	3 Medical Instrument Stocks to Counter Industry Woes Using GenAI (Zacks)
Dec-26-25 12:20PM	EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
Dec-17-25 12:01PM	HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases (Zacks)
Dec-11-25 10:06AM	ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries (Zacks)
Dec-10-25 12:40PM	PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor (Zacks)
08:59AM	Here's Why You Should Add Cencora Stock to Your Portfolio Now (Zacks)
Dec-08-25 08:23AM	Beat the Market the Zacks Way: Veracyte, Las Vegas Sands, 3M in Focus (Zacks)
Dec-03-25 11:59AM	EHC Opens New Lake Worth Rehab Hospital to Meet Rising Demand (Zacks)
Dec-02-25 09:45AM	Why Veracyte (VCYT) is a Top Growth Stock for the Long-Term (Zacks)
Nov-19-25 12:24PM	TDOC Partners With TytoCare to Expand At-Home Exam Capabilities (Zacks)
Nov-13-25 11:07AM	Ensign Group Shares Decline 2.2% Despite Q3 Earnings Beat (Zacks) -5.74%
Nov-11-25 12:24PM	Encompass Health Shares Down 8% Despite Q3 Earnings & Revenue Beat (Zacks)
07:26AM	VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up (Zacks)
Nov-10-25 12:55PM	Tenet Healthcare Shares Down 5% Despite Q3 Earnings Beat (Zacks)
Nov-06-25 12:09PM	Pediatrix Medical Q3 Earnings Beat Estimates on Declining Expenses (Zacks) -9.45%
08:30AM	Veracyte to Participate in Upcoming Investor Conferences (Business Wire)
Nov-05-25 12:03AM	Veracyte Inc (VCYT) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) +27.46%
Nov-04-25 06:25PM	Veracyte (VCYT) Q3 Earnings and Revenues Beat Estimates (Zacks)
05:31PM	Veracyte: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Veracyte Announces Third Quarter 2025 Financial Results (Business Wire)
Nov-03-25 04:15PM	Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing (Business Wire)
07:31AM	What To Expect From Veracyte Inc (VCYT) Q3 2025 Earnings (GuruFocus.com)
Oct-31-25 10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
Oct-30-25 12:24PM	ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
Oct-29-25 09:08AM	CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash (Zacks)
Oct-28-25 10:01AM	LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down (Zacks)
Oct-24-25 01:53PM	ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates (Zacks)
Oct-22-25 10:56AM	ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
09:23AM	Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up (Zacks)
09:16AM	Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
08:30AM	Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today (Zacks)
Oct-21-25 09:29AM	Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise (Zacks)
Oct-16-25 09:35AM	Veracyte (VCYT) Crossed Above the 20-Day Moving Average: What That Means for Investors (Zacks)
08:06AM	Do You Believe in the Upside Potential of Veracyte (VCYT) (Insider Monkey)

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. It intends to treat thyroid cancer, improve lung cancer screening, and clarify the diagnosis of idiopathic pulmonary fibrosis. The company was founded by Bonnie H. Anderson and Y. Douglas Dolginow on August 15, 2006 and is headquartered in South San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McGuire Annie	SVP, General Counsel	Dec 16 '25	Sale	43.13	10,739	463,204	67,760	Dec 17 04:35 PM
ANN MCGUIRE	Officer	Dec 16 '25	Proposed Sale	43.53	10,739	467,469		Dec 16 04:30 PM
EASTHAM KARIN	Director	Dec 05 '25	Option Exercise	7.77	20,000	155,400	33,554	Dec 08 04:34 PM
EASTHAM KARIN	Director	Dec 05 '25	Sale	45.45	20,000	908,923	13,554	Dec 08 04:34 PM
KARIN EASTHAM	Director	Dec 05 '25	Proposed Sale	47.41	20,000	948,200		Dec 05 04:26 PM
McGuire Annie	SVP, General Counsel	Dec 04 '25	Sale	47.30	1,422	67,261	78,499	Dec 04 07:44 PM
Chambers Rebecca	Chief Financial Officer	Dec 04 '25	Sale	46.84	13,278	621,955	109,496	Dec 04 07:44 PM
Stapley Marc	Chief Executive Officer	Dec 04 '25	Sale	47.09	7,668	361,076	318,603	Dec 04 07:44 PM
Leite John	Chief Commercial Officer-CLIA	Dec 04 '25	Sale	47.51	1,278	60,718	82,113	Dec 04 07:43 PM
ANN MCGUIRE	Officer	Dec 04 '25	Proposed Sale	47.75	1,422	67,900		Dec 04 04:39 PM
REBECCA CHAMBERS	Officer	Dec 04 '25	Proposed Sale	47.75	13,278	634,024		Dec 04 04:39 PM
MARC STAPLEY	Director	Dec 04 '25	Proposed Sale	47.75	7,668	366,147		Dec 04 04:38 PM
Leite John	Chief Commercial Officer-CLIA	Nov 25 '25	Sale	50.00	2,808	140,400	86,291	Nov 26 04:27 PM
JONES EVAN/ FA	Director	Nov 25 '25	Sale	50.25	1,106	55,576	29,362	Nov 26 04:27 PM
Evan Jones	Director	Nov 25 '25	Proposed Sale	49.38	5,000	246,900		Nov 25 07:25 PM
John Leite	Officer	Nov 25 '25	Proposed Sale	46.70	4,086	190,816		Nov 25 04:28 PM
Holstein Jens	Director	Nov 20 '25	Sale	42.36	10,000	423,563	27,199	Nov 21 04:19 PM
JENS HOLSTEIN	Director	Nov 20 '25	Proposed Sale	42.36	10,000	423,563		Nov 20 04:03 PM
Wygant Jonathan	VP, Chief Accounting Officer	Nov 07 '25	Sale	40.21	5,818	233,929	43,847	Nov 12 04:25 PM
Wygant Jonathan	VP, Chief Accounting Officer	Nov 10 '25	Sale	42.33	5,102	215,978	38,745	Nov 12 04:25 PM
McGuire Annie	SVP, General Counsel	Nov 05 '25	Sale	40.00	6,466	258,640	82,973	Nov 07 04:10 PM
JONES EVAN/ FA	Director	Nov 05 '25	Option Exercise	6.94	30,000	208,200	73,664	Nov 07 04:10 PM
JONES EVAN/ FA	Director	Nov 05 '25	Sale	45.06	43,196	1,946,288	30,468	Nov 07 04:10 PM
EASTHAM KARIN	Director	Nov 05 '25	Sale	40.02	9,674	387,191	13,554	Nov 07 04:10 PM
Chambers Rebecca	Chief Financial Officer	Nov 05 '25	Sale	41.00	7,000	287,000	126,158	Nov 07 04:10 PM
Evan Jones	Director	Nov 05 '25	Proposed Sale	46.04	43,196	1,988,744		Nov 05 09:47 PM
KARIN EASTHAM	Director	Nov 05 '25	Proposed Sale	36.12	9,674	349,425		Nov 05 04:18 PM
ANN MCGUIRE	Officer	Nov 05 '25	Proposed Sale	36.12	6,466	233,552		Nov 05 04:18 PM
REBECCA CHAMBERS	Officer	Nov 05 '25	Proposed Sale	36.12	7,000	252,840		Nov 05 04:17 PM
Febbo Phillip G.	Chief Scientific & Med Officer	Oct 06 '25	Sale	36.02	8,349	300,709	92,441	Oct 07 04:27 PM
PHILLIP FEBBO	Officer	Oct 06 '25	Proposed Sale	36.00	8,349	300,564		Oct 06 04:19 PM
Leite John	Chief Commercial Officer-CLIA	Oct 01 '25	Sale	35.00	2,539	88,865	89,099	Oct 03 04:16 PM
EPSTEIN ROBERT S	Director	Oct 01 '25	Option Exercise	7.94	10,000	79,400	83,919	Oct 03 04:16 PM
EPSTEIN ROBERT S	Director	Oct 01 '25	Sale	35.08	21,473	753,204	62,446	Oct 03 04:16 PM
McGuire Annie	SVP, General Counsel	Oct 01 '25	Sale	35.00	2,160	75,608	89,439	Oct 03 04:16 PM
ROBERT S EPSTEIN	Director	Oct 01 '25	Proposed Sale	34.33	21,473	737,168		Oct 01 04:27 PM
John Leite	Officer	Oct 01 '25	Proposed Sale	34.33	2,539	87,164		Oct 01 04:27 PM
ANN MCGUIRE	Officer	Oct 01 '25	Proposed Sale	34.33	2,160	74,153		Oct 01 04:26 PM
McGuire Annie	SVP, General Counsel	Sep 19 '25	Sale	33.69	2,283	76,920	91,599	Sep 23 04:18 PM
ANN MCGUIRE	Officer	Sep 19 '25	Proposed Sale	33.23	2,283	75,864		Sep 19 04:25 PM
Stapley Marc	Chief Executive Officer	Sep 04 '25	Sale	30.41	7,667	233,133	334,185	Sep 08 04:33 PM
MARC STAPLEY	Director	Sep 04 '25	Proposed Sale	30.62	7,667	234,764		Sep 04 04:26 PM
EASTHAM KARIN	Director	Jun 13 '25	Sale	26.66	4,590	122,388	13,907	Jun 17 04:21 PM
Bhanji Muna	Director	Jun 13 '25	Sale	26.67	4,589	122,367	29,989	Jun 17 04:21 PM
KARIN EASTHAM	Director	Jun 13 '25	Proposed Sale	26.69	4,590	122,507		Jun 13 04:46 PM
MUNA BHANJI	Director	Jun 13 '25	Proposed Sale	26.69	4,589	122,480		Jun 13 04:45 PM
Leite John	Chief Commercial Officer-CLIA	Jun 04 '25	Sale	27.20	2,809	76,410	94,540	Jun 06 04:19 PM
JOHN LEITE	Officer	Jun 04 '25	Proposed Sale	26.50	2,809	74,438		Jun 04 04:21 PM
Leite John	Chief Commercial Officer-CLIA	Mar 07 '25	Sale	31.66	7,411	234,630	100,249	Mar 10 04:43 PM
JOHN LEITE	Officer	Mar 07 '25	Proposed Sale	32.51	7,411	240,932		Mar 07 04:17 PM
ANN MCGUIRE	Officer	Mar 04 '25	Proposed Sale	33.56	1,142	38,326		Mar 04 05:12 PM
MARC STAPLEY	Director	Mar 04 '25	Proposed Sale	33.56	52,697	1,768,511		Mar 04 05:07 PM
PHILLIP FEBBO	Officer	Mar 04 '25	Proposed Sale	33.56	8,037	269,722		Mar 04 05:07 PM
Leite John	Chief Commercial Officer-CLIA	Feb 27 '25	Sale	33.84	5,746	194,445	79,070	Mar 03 04:30 PM

PGNY

Progyny Inc

VCYT

Veracyte Inc

Upgrade your FINVIZ experience